US Stock MarketDetailed Quotes

GIFOF GRIFOLS SA NON-CUM PRF SHS EUR0.05 (B) POST CONS

Watchlist
  • 6.192
  • 0.0000.00%
Close Mar 15 16:00 ET
4.20BMarket Cap62.55P/E (TTM)

About GRIFOLS SA NON-CUM PRF SHS EUR0.05 (B) POST CONS Company

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Company Profile

SymbolGIFOF
Company NameGRIFOLS SA NON-CUM PRF SHS EUR0.05 (B) POST CONS
Listing Date06/02/2011
Founded1940
MarketPink Market
Employees23744
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressAvinguda de la Generalitat, 152-158,Parc de Negocis Can Sant Joan,Sant Cugat del Vallès
CityBarcelona
ProvinceCatalonia
CountrySpain
Zip Code08174
Phone34-93-571-02-21

Company Executives

  • Name
  • Position
  • Salary
  • Raimon Grifols Roura
  • Vice Chairman of the Board and Co-Chief Executive Officer
  • --
  • Víctor Grifols Deu
  • Director and Co-Chief Executive Officer
  • --
  • Alfredo Arroyo Guerra
  • Chief Financial Officer
  • --
  • Vicente Blanquer Torre
  • Chief Quality Officer
  • --
  • David Ian Bell
  • General Counsel and Chief Corporate Development, Legal and Data Protection Officer
  • --
  • Daniel Fleta Coit
  • Chief Industrial Services Officer
  • --
  • Albert Grifols Coma-Cros
  • Chief Scientific Innovation Officer
  • --
  • Maria Teresa Rioné Llano
  • Chief Communications Officer
  • --
  • Montserrat Gaja Llamas
  • Chief Human Resources Officer
  • --
  • Ignacio Ramal Subira
  • Chief Internal Audit & Enterprise Risk Manager
  • --
  • Tomas Daga Gelabert
  • Director and Vice Secretary of the Board
  • --
  • Nuria Martin Barnes
  • Secretary non-member of the Board
  • --
  • Fernando Rodriguez Haro
  • Executive Vice President, Transformation
  • --
  • Francisco Javier Guix Huguet
  • Vice President, Healthcare Solutions
  • --
  • Lluis Pons Gomez
  • Senior Vice President, Strategy
  • --
  • Thomas H. Glanzmann
  • Executive Chairman of the Board
  • --
  • Alberto Grifols Roura
  • President, Bio Supplies business unit
  • --
  • Dr. Antonio Martinez Martinez
  • President, Diagnostic business unit
  • --
  • Jordi Balsells Valls
  • President, Plasma Procurement
  • --
  • Maria Pia D’Urbano
  • President, Biopharma
  • --
  • Carina Szpilka Lazaro
  • Lead Independent Director
  • --
  • Inigo Sanchez-Asiain Mardones
  • Independent Director
  • --
  • James Costos
  • Independent Director
  • --
  • Enriqueta Felip Font
  • Independent Director
  • --
  • Montserrat Munoz Abellana
  • Independent Director
  • --
  • Susana Gonzalez Rodriguez
  • Independent Director
  • --
  • Víctor Grifols Roura
  • Honorary Chairperson
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg